Navigation Links
Genesis Pharmaceuticals Affirms Operating Income Guidance, Adjusts Revenue Guidance for Fiscal 2009
Date:4/2/2009

nule, syrup and electuary form.

Safe Harbor Statement

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the Company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from anticipated or predicted results, and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's ability to obtain raw materials needed in manufacturing, the continuing employment of key employees, the failure risks inherent in testing any new drug, the possibility that regulatory approvals may be delayed or become unavailable, patent or licensing concerns that may include litigation, direct competition from other manufacturers and product obsolescence. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

    For more information, please contact:

    Genesis Pharmaceuticals Enterprises, Inc.
     Ms. Elsa Sung, CFO
     Tel:   +1-954-727-8435
     Email: elsasung@jiangbo.com
     Web:   http:// www.genesispharmaceuticals.com

    CCG Investor Relations, Inc.
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

'/>"/>
SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardiogenesis Reports Fourth Quarter and Fiscal Year 2008 Results
2. New Directions in Angioedema: A Focus on Pathogenesis and Classification
3. Angiogenesis inhibitor improves brain tumor survival by reducing edema
4. CFO of Genesis Pharmaceuticals Gives Live Interview on Bloomberg TV Asia
5. Cardiogenesis Corporation to Report 2008 Fourth Quarter and Year-End Results on March 31st
6. Study sheds light on angiogenesis inhibitors, points to limitations, solutions
7. Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone
8. Genesis Successfully Defends Multi-Million Dollar Arbitration Filed by CRG and CRGP; Related Parties Withdraw Remaining Demands for Arbitration Against Genesis
9. Genesis Pharmaceuticals Successfully Defends Itself in a Multi-Million Dollar Arbitration, Two Other Arbitration Proceedings Against Genesis are Withdrawn
10. Angiogenesis linked to poor survival in patients with rare type of ovarian cancer
11. Genesis Pharmaceuticals Enters Into Agreement to Purchase Hongrui Pharmaceuticals, and Acquire 22 New Traditional Chinese Medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Scientists at the University of Pennsylvania believe they ... patients benefit from immunotherapy; surgery may be the key. ... new research. Click here to read it now. ... and pulmonology theorized that, because large mesothelioma tumors have ... drugs might work better if the tumor size could ...
(Date:5/26/2015)... The best and most convenient method of tracking ... pocket. That’s because Life Fitness, the global leader in ... sync with the most popular built-in fitness mobile apps ... automatically transmitting data collected directly from Life Fitness cardio ... the millions of iPhone and Android users and exercisers ...
(Date:5/26/2015)... 26, 2015 General Networks Corporation ... Corporation. The alliance ensures joint customers will benefit ... General Networks’ expertise in building enterprise content and ... will help customers integrate, manage and operationalize their ... processes. , “Our customers are seeking tools to ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 ... ceremonies during the Memorial Day weekend, celebrating the ... occurred on Pacifica’s picturesque Ladera Lane campus, located ... faculty, and alumni traveled to Santa Barbara from ... events. , The 2015 commencement ceremonies ...
(Date:5/26/2015)... May 26, 2015 Dearborn Ear, Nose ... the launch of their new and improved website to ... and potential patients. Dearborn Ear, Nose & Throat’s new ... visitors to view the website seamlessly on any desktop ... to the Dearborn Ear, Nose & Throat ...
Breaking Medicine News(10 mins):Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 3Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 3Health News:Dearborn Ear, Nose & Throat Launches ‘Responsive Design’ Website 2
... ordering chest CT examinations translates into positive examinations three-quarters ... study, conducted at Massachusetts General Hospital in Boston, of ... a decision support system, found that 76% of patients ... "Rising concerns about radiation risks, imaging growth and reimbursement ...
... A new analysis suggests the benefits of mammography screening ... 40 to 49 who are at an increased risk of ... out of every five American women. The researchers also ... to film mammography. These findings, with contributions from three national ...
... State University researchers have invented a protein purifier that ... The details of the invention, which appear in a ... that MSU chemists Merlin Bruening and Greg Baker,s high-performance ... step in the development of some new drugs. ...
... Dotinga HealthDay Reporter , MONDAY, April 30 (HealthDay ... a commonly used insecticide to unusual changes in the brain ... that the pesticide is at fault. The findings ... as chlorpyrifos, which is used to treat farm products in ...
... officer calling for backup while also keeping a strong hold ... a two-tier approach to fighting off a threat, new research ... the first time, the scientists managed to capture that reaction ... model of virus-infected brain cells, while also sending signals to ...
... Control and Prevention (CDC) found that one-third of U.S. adults ... depression. According to findings that appear today in Arthritis ... behalf of the American College of Rheumatology (ACR), anxiety is ... despite more clinical focus on the latter mental health condition. ...
Cached Medicine News:Health News:Research examines when benefits of screening mammography outweigh the harms for women in their 40s 2Health News:Research examines when benefits of screening mammography outweigh the harms for women in their 40s 3Health News:MSU invention could help pharmaceutical industry save money 2Health News:Insecticide Linked to Brain Abnormalities in Kids 2Health News:Insecticide Linked to Brain Abnormalities in Kids 3Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 2Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 3Health News:One-third of adult Americans with arthritis battle anxiety or depression 2
(Date:5/26/2015)... JUNCTION, N.J. , May 26, 2015 ... critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine adsorber ... Dr. Phillip Chan , Chief Executive Officer, will ... on Monday, June 1, 2015 at 10:30AM PDT / ... Los Angeles , California.  Dr. Chan will also ...
(Date:5/26/2015)... 26, 2015  Shapiro+Raj, a leading independent insights and ... to Managing Director. In her new role, she will ... CarbonSix, Shapiro+Raj,s pharmaceutical practice as well as the company,s ... been on a strong growth trajectory in double digits ... assignments from existing clients and strategic new business wins. ...
(Date:5/26/2015)... -- Connected health infrastructure is emerging as a ... diagnosis, monitoring and prevention in the healthcare industry. ... must first ensure that interoperability and connectivity standards ... http://photos.prnewswire.com/prnh/20150526/218313LOGO New analysis from ... and Interoperability, finds that the adoption of connected ...
Breaking Medicine Technology:CytoSorbents to Present at the LD Micro Invitational on June 1st 2CytoSorbents to Present at the LD Micro Invitational on June 1st 3Shapiro+Raj Promotes Kim Mizrahi to Managing Director for New York 2Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 2Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 3
... Pharmaceuticals Inc. (Nasdaq: CPIX ) announced ... lots of Acetadote® (acetylcysteine) Injection, the Company,s injectable treatment ... a potentially toxic quantity of acetaminophen. Cumberland informed the ... to voluntarily recall these lots of Acetadote as a ...
... 2010 Stereotaxis, Inc. (Nasdaq: STXS ) ... the Remote Magnetic Navigation System in the electrophysiology (EP) ... train clinicians planning to install Stereotaxis at their own ... Navigation System growing steadily, there is significant new demand ...
Cached Medicine Technology:Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials 2Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials 3Stereotaxis Announces Global Initial Training Site at University of Chicago 2Stereotaxis Announces Global Initial Training Site at University of Chicago 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: